A nanotechnology-based delivery system: Nanobots. Novel vehicles for molecular medicine.

Jacob, T; Hemavathy, K; Jacob, J; Hingorani, A; Marks, N; Ascher, E

Jacob, T; Hemavathy, K; Jacob, J; Hingorani, A; Marks, N; Ascher, E.

Affiliation

Jacob T; Clinical Trials Unit and Translational Research, Maimonides Medical Center, Brooklyn, New York, NY, USA. tjacob@maimonidesmed.org

J Cardiovasc Surg (Torino) ; 52(2): 159-67, 2011 Apr.

Article in En | MEDLINE | ID: mdl-21460765

Subject(s)

Muscle, Smooth, Vascular/metabolism; Myocytes, Smooth Muscle/metabolism; Nanoparticles; Nanotechnology/methods; Polyglactin 910/chemistry; Transfection/methods; Tumor Suppressor Protein p53/biosynthesis; Blotting, Western; Cell Proliferation; Cell Survival; Endothelial Cells/metabolism; Green Fluorescent Proteins/biosynthesis; Green Fluorescent Proteins/genetics; HEK293 Cells; Humans; Microfilament Proteins/genetics; Muscle Proteins/genetics; Promoter Regions, Genetic; Recombinant Fusion Proteins/biosynthesis; Time Factors; Tumor Suppressor Protein p53/genetics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polyglactin 910 / Transfection / Tumor Suppressor Protein p53 / Nanotechnology / Myocytes, Smooth Muscle / Nanoparticles / Muscle, Smooth, Vascular Limits: Humans Language: En Journal: J Cardiovasc Surg (Torino) Year: 2011 Document type: Article Affiliation country: United States Country of publication: Italy

Search on Google

Add to My VHL

XML

PubMed Links